The study used a rat model of moderate protein restriction exclusively during fetal and early neonatal life, which has been established to cause intrauterine early growth retardation, to investigate possible association between adipocyte glucose utilisation and leptin secretion in vivo. DESIGN: These rats, termed early protein restricted, were transferred to a diet containing the standard amount of protein at weaning and remained on this diet until adulthood, at which time adipocyte glucose utilisation and leptin secretion was compared with that of age-matched controls. Insulin status was modulated by acute (2 h) insulin infusion at a constant rate (4.2 mU=min per kg) to elevate insulin to the high physiological range. Euglycaemia was maintained by variable glucose infusion. MEASUREMENTS: Glucose utilisation was measured in vivo in conscious unrestrained rats using 2-deoxy[1-3 H] glucose. Leptin concentrations (measured by radioimmunoassay) and whole-body glucose kinetics (measured using [3-3 H] glucose) were studied in the postabsorptive state and after acute insulin stimulation. RESULTS: Adipose-tissue glucose utilisation rates in vivo tended to be higher in the post-absorptive state and were consistently 1.8 -3.0-fold higher after insulin stimulation in the early-protein-restricted group compared with the control group. Both the absolute increase in leptin concentration elicited by hyperinsulinaemia and the magnitude of the effect of insulin to elevate plasma leptin levels were greater in the early-protein-restricted group compared with the control group (by 2.2-fold and 1.6-fold, respectively). The effect of insulin to stimulate R d was much greater in the early-protein-restricted group (4.1-fold) than in the control group (2.2-fold) and the absolute increase in R d elicited by insulin was 43% higher in the early-protein-restricted group than in the control group.
Introduction
By virtue of its large mass, skeletal muscle is thought to make the largest contribution to glucose disposal in lean rodents and man, particularly under conditions of insulin stimulation. 1, 2 However, studies with transgenic and knock-out models have suggested a greater role for adipose tissue in systemic glucose homeostasis than previously recognised. Thus, targetted over-expression of the insulin-regulated glucose transporter GLUT4 in adipose tissue enhances wholebody insulin sensitivity and glucose tolerance, 3, 4 whereas adipose-specific knock-out of GLUT4 results in a degree of insulin resistance comparable to that observed with muscle specific knock-out. 5 The question has thus been raised as to whether systemic insulin resistance results directly from altered glucose transport or indirectly from possible effects of altered glucose uptake on the release of other molecules from adipocytes.
Leptin, synthesised by and secreted from adipose tissue, is involved in the regulation of food intake, growth and metabolism 6, 7 (reviewed in Fruhbeck and Salvador 8 ) . Although the transcription factors ADD-1=SREBP-1 9 and members of the forkhead family 10 may link changes in insulin levels to adipocyte gene expression, it remains controversial as to whether effects of insulin to stimulate leptin secretion are rapid enough to comprise an acute feedback system for nutrient sensing. Some studies have been unable to demonstrate an acute effect of insulin on leptin secretion; 11 others have found that prolonged ( > 24 h) periods of hyperinsulinaemia or supraphysiological insulin concentrations are required to observe a leptin response. 12 -14 Recent data suggest that the acute nutritional regulation of leptin secretion may be more related to glucose metabolism than to insulin levels, as assessed by the rate of glucose infusion required to maintain glycaemia during an insulin clamp. 15 Leptin levels correlate better with plasma glucose than plasma insulin concentrations in mice injected with glucose, 16, 17 and leptin release from adipocytes parallels glucose metabolism. 18, 19 A small birth weight is associated with insulin resistance and increased prevalence of the insulin resistance syndrome in later life. 20 -23 Adults with a low birthweight have higher leptin concentrations than would be expected from their degree of obesity. 24 In the rat, poor early (fetal and postnatal) protein nutrition enhances whole-body 25 and adipocyte insulin sensitivity 26 -28 in young rats. Importantly, early growth retardation elicited by a low-protein diet is associated with permanent alterations in adipocyte insulin sensitivity and signalling 25,26,28 -31 that might be predicted to influence adipocyte glucose utilisation. The present study used this model to assess the potential impact of early growth retardation on the acute response of adipocyte glucose utilisation to hyperinsulinaemia and its relationship to leptin secretion.
Methods

Materials
Kits for determination of plasma insulin concentrations by radioimmunoassay were from Phadeseph Pharmacia, Uppsala, Sweden. Plasma leptin was measured by radioimmunoassay using kits from Linco Research, St Louis, MO, USA. Human Actrapid insulin was from Novo Nordisk, Bagsvaerd, Denmark. Other biochemicals and chemicals, including glucose assay kits, were from Roche Diagnostics, Lewes, East Sussex, UK or from Sigma, Poole, Dorset, UK. Female Wistar rats were obtained from Charles River Ltd, Margate, Kent, UK.
Diets
The Hope Farms BV, Woerden, The Netherlands prepared isocaloric control and protein-restricted diets. The control diet (C) contained 20% protein (casein (22 g=100 g diet; 0.88 g protein=g) supplemented with DL-methionine (0.2 g=100 g diet)), 63.15% carbohydrate (cerelose (55.15 g=100 g diet) and corn starch (8 g=100 g diet)) and 4.3% lipid (soybean oil) by weight, and other dietary components as specified in Holness and Sugden. 26 The isocaloric protein-restricted diet contained 8% protein (casein (9 g=100 g diet; 0.88 g protein=g) supplemented with DLmethionine (0.08 g=100 g diet)), 76.17% carbohydrate (cerelose (68.17 g=100 g diet) and corn starch (8 g=100 g diet)) and 4.3% lipid (soybean oil) by weight. Isocaloricity was maintained by increasing the carbohydrate content of the protein-restricted diet to 76%. 25, 26 Animals and housing All studies were conducted in adherence to the regulations of the UK Animal Scientific Procedures Act (1986). Female Wistar rats of 200 -250 g were subjected to a standard light (08:00 -20:00) -dark cycle in a temperature-controlled room (21 AE 2 C). The rats were housed in individual cages and were given free access to food and water. They were then timemated by the appearance of sperm plugs (day 0 of pregnancy), immediately randomly assigned to either control or protein-restricted diet, and maintained on the same diet throughout pregnancy and lactation. The provision of the protein-restricted diet did not influence maternal food intake or body weight gain during pregnancy, 32 and litters of normal numerical size were produced (results not shown). Weight at birth was significantly (P < 0.05) reduced by 7.4 AE 1.2% (n ¼ 9 litters in each group) in the proteinrestricted offspring. Litters containing less than 10 pups or greater than 15 pups were excluded from the study. The sexes were separated at 26 days after birth. The female offspring, termed control and early-protein-restricted groups, were fed 20% protein diet from weaning. At 150 days of age body weights of the control and early-protein-restricted rats were not statistically different (control, 291 AE 7% (n ¼ 19); earlyprotein-restricted, 275 AE 6% (n ¼ 19)). At 5 -7 days before the in vivo experiments were performed, the rats were anaesthetized with Hypnorm (fentanyl citrate (0.315 mg=ml)=fluani-sone (10 mg=ml); 1 ml=kg i.p.) and diazepam (5 mg=ml; 1 ml=kg i.p.) anaesthesia. Indwelling catheters were inserted in the internal jugular veins and both catheters were exteriorised through the skin at the back of the neck. 25, 26 Wholebody glucose kinetics and plasma leptin responses were studied in the postabsorptive state after a 6 h fast and after 2 h of euglycemic hyperinsulinemia.
Hyperinsulinaemic euglycemic clamp studies Conscious unrestrained rats underwent hyperinsulinemic euglycemic clamps as described previously 25, 26 for 2 h. During these hyperinsulinaemic euglycaemic clamps, insulin (human Actrapid) was administered as a prime (10 mU=kg over 20 s) continuous (4.2 mU=min per kg) infusion (infusion rate 20 ml=min), and a variable infusion of a 30% glucose solution was started and adjusted to maintain the blood Early growth and the acute regulation of leptin by insulin MJ Holness glucose concentration at $ 4.35 mmol=l, with a coefficient of variation < 5% in all studies. The GIR is defined as the glucose infusion rate required to maintain blood glucose at the target concentration. Whole-body glucose kinetics were estimated in awake, unstressed, freely moving rats by use of primed (1 mCi) continuous (0.4 mCi=min per rat) intravenous infusion of [3-3 H] glucose as described by Holness. 25, 26 A steady-state of glucose-specific activity in the basal state was achieved by 60 min. Blood samples were obtained at 60, 75 and 90 min after beginning tracer infusion for determination of basal glucose-specific activity and insulin was infused from 90 min onwards. The H] glucose infusion was continued for a further 120 min. Steady-state conditions were achieved after 90 min, after which three blood samples (100 ml) were taken at 15 min intervals (90, 105 and 120 min) for measurement of glucose-specific activity. Plasma samples for determination of glucose were obtained at 5 -10 min intervals throughout the clamp studies. Wholebody glucose disposal rates (R d ) were calculated as described previously. 25, 26 Plasma samples for insulin and leptin were collected at the end of each infusion. The total amount of blood withdrawn during the clamp study was < 1.5 ml. 1,33 Blood samples (100 ml) for determination of blood glucose concentrations and plasma tracer concentrations were obtained at 1, 3, 5, 10, 20, 40 and 60 min after [ 3 H]2DG bolus administration. Throughout the study, the rats were awake and moving freely, with the connecting tubing suspended overhead. At the end of the 60 min study, a final blood sample (500 ml) was added to a heparinised tube, immediately centrifuged at 4 C and plasma was frozen at 7 20 C for subsequent insulin determinations. Rats were killed by the intravenous injection of sodium pentobarbitone (60 mg=kg body wt) via the right jugular cannula. Individual adipose tissue depots were freezeclamped when locomotor activity had ceased (within 5 s). The freeze-clamped tissues were stored in liquid nitrogen until analysis as described previously. 33 No correction has been made for possible discrimination against 2-deoxyglucose vs glucose with respect to glucose transport and phosphorylation, and hence rates of tissue accumulation of 2-deoxy-D- [1- 3 H] glucose 6-phosphate are referred to as glucose utilisation indices (GUI).
Estimations of glucose utilisation in vivo
Biochemical determinations
Blood glucose concentrations during the clamp were determined using a glucose analyser (YSI, Yellow Springs, Ohio, USA). In other studies, blood glucose concentrations were measured in deproteinised samples by the glucose oxidase method using kits supplied by Roche Diagnostics. Plasma insulin was measured by RIA, using rat insulin standards (Rat Insulin Kit, Phadeseph Pharmacia). Plasma leptin concentrations were determined by a commercially available RIA, using rat leptin standards (Rat Leptin RIA Kit, Linco Research).
Statistical analyses
Statistical comparisons were made with StatView (Abacus Concepts Inc., Berkeley, CA). Multiple comparisons were made by analysis of varaince (ANOVA) and individual comparisons by Fisher post hoc tests. Comparisons between just two sets of data were performed with the unpaired Student's t-test. The criterion for significance was set at P < 0.05. All data are presented as the means AE s.e.m.
Results
Early-protein-restriction increases adipose tissue glucose utilisation in vivo and augments excursions in glucose utilisation evoked by modulating, insulin status Rates of glucose utilisation (transport þ phosphorylation) in vivo (from 2-deoxy-D- [1- 3 H] glucose 6-phosphate accumulation) for three intra-abdominal adipose tissue depots (parametrial, perirenal and mesenteric) and two superficial adipose tissue depots (inguinal subcutaneous and interscapular) were measured in control and early-protein-restricted rats in the postabsorptive state after 6 h of starvation ( Figure  1A ) and after 2 h of insulin stimulation ( Figure 1B) . Rates of glucose utilisation by each of the adipose tissue depots in vivo in the post-absorptive state tended to be higher in earlyprotein-restricted rats than in control rats ( Figure 1A ), although this effect only achieved statistical significance in the parametrial depot (3.2-fold; P < 0.05). In the control group, insulin infusion (2 h) elevated GUI values in the parametrial (3.1-fold; P < 0.001) and perirenal (2.6-fold; P < 0.05) depots, and to a lesser extent in the subcutaneous (1.6-fold; P < 0.01) and interscapular (2.0-fold; P < 0.05) depots, but not in the mesenteric depot (Figure 1 ). Trends towards increased glucose utilisation were observed in all of the adipose tissue depots of the early-protein-restricted rats ( Figure 1 ) and, importantly, rates of glucose utilisation by adipose tissue of the early-protein-restricted rats after insulin stimulation were consistently 1.8 -3.0-fold higher than those of the control group ( Figure 1B) , even though plasma insulin and blood glucose concentrations did not differ significantly between the groups (Table 1) . Importantly, the excursions in rates of adipose tissue glucose utilisation evoked by changes in insulin status were, with the exception of the parametrial depot, greatly augmented by earlyprotein-restriction (compare Figure 1A and B) .
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Early-protein-restriction modulates leptin secretion in vivo If altered rates of glucose utilisation by adipose tissue are important for acute modulation of adipocyte leptin secretion, it would be predicted that early protein restriction would lead to greater excursions in leptin concentrations in response to acute modulation of insulin status. Both the absolute increase in leptin concentration elicited by hyperinsulinaemia and the magnitude of the effect of insulin to elevate plasma leptin levels were greater in the early-proteinrestricted group compared with the control group (by 2.2-fold and 1.6-fold, respectively; Figure 2 ).
Plasma leptin concentrations in relation to whole-body glucose disposal R d values in the postabsorptive state were significantly lower in early-protein-restricted rats compared with control rats (by 45%; P < 0.01, Figure 3A ), but the magnitude of the effect of insulin to stimulate R d (estimated at steady-state hyperinsulinaemia) was much greater in the early-proteinrestricted group (4.1-fold; P < 0.01 vs basal) than in the control group (2.2-fold; P < 0.001 vs basal) and the absolute increase in R d elicited by insulin was 43% higher in the earlyprotein-restricted group than in the control group. Thus, the individual responses of R d to euglycaemic hyperinsulinaemia bore a striking parallel to the pattern of changes in plasma leptin concentrations observed in response to euglycaemic hyperinsulinaemia.
Wellhoener et al, 15 suggested that the rate of glucose infusion required to maintain glycaemia during an insulin clamp (GIR) was a possible indicator of the acute nutritional Values are means AE s.e.m. for five to seven rats in each group. Each data group comprised rats from at least three separate litters. Statistically significant differences between control and early-protein-restricted rats are indicated by *P < 0.05. Early growth and the acute regulation of leptin by insulin MJ Holness regulation of leptin secretion. In the present experiments, the steady-state GIR required to maintain euglycaemia between 90 and 120 min of hyperinsulinaemia was increased (by 47%, P < 0.01) in the early-protein-restricted group compared with control ( Figure 3B ).
Discussion
The present study used a rat model, protein restriction during fetal and early neonatal life, which leads to early growth retardation and a low birthweight 29 to examine the relationship between adipocyte glucose utilisation and leptin secretion in vivo. The results show conclusively that poor early growth (early-protein-restricted group) greatly exaggerates the excursions in adipose tissue glucose utilisation that can be evoked by changes in insulin status in vivo and, at the same time, excursions in plasma leptin levels are augmented. It is likely that the former effect is related to an effect of early growth retardation induced by protein restriction to elevate adipocyte levels of insulin receptors and to increase basal and insulin-stimulated levels of insulin receptor substrate-1 (IRS-1) associated phosphatidylinositol 3-kinase activity 28 and Protein kinase B (PKB)=Akt activity in adipocytes. 31 Although it remains to be established directly whether enhanced glucose uptake is a prerequisite for enhanced insulin-stimulated leptin secretion in the earlyprotein-restriction model, the results are consistent with the concept that early protein restriction enhances the leptin response by increasing insulin sensitivity of adipocyte glucose uptake. The increases in glucose utilisation elicited by hyperinsulinaemia were greater in three of the five adipose tissue depots (namely, mesenteric, subcutaneous and interscapular) in early-protein-restricted rats compared with control rats. Insulin sensitivity in terms of glucose uptake was similar or lower in parametrial and perirenal adipose tissue depots of early-protein-restricted rats compared with control rats. There is evidence that different adipose tissue depots contribute disproportionately to circulating leptin concentrations. Thus, leptin secretion is greater in subcutaneous than in omental adipose tissue of obese subjects, 34, 35 although no difference is observed in non-obese subjects. 36 It is therefore possible that the elevated insulin-stimulated leptin levels in the early-protein-restricted rats reflect enhanced rates of insulin-stimulated glucose uptake in the subcutaneous adipose tissue depot. (A) . GIR, calculated from the rate of glucose infusion required to maintain blood glucose at the target concentration during the period from 90 to 120 min after the initiation of insulin infusion, is shown in (B). Values are means AE s.e.m. for five to seven rats in each group. Each data group was comprised of rats from at least three separate litters. Statistically significant effects of early-protein-restriction are indicated by *P < 0.05, **P < 0.01.
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The data may be relevant to possible associations between a low birthweight and elevated leptin concentrations in later life. 24 Early-protein-restricted rats were examined in young adulthood after transfer from a low-protein diet to a diet containing the standard amount of protein at weaning, showing that changes in glucose and leptin metabolism are a consequence of a persistent effect induced in early life. It has been suggested that elevated leptin levels in people of low birthweight might be a consequence of sustained hyperinsulinaemia. However, the data in the present study, if they can be extrapolated to man, imply that babies of low birthweight that subsequently go on to have high leptin concentrations may do so because of an enhanced leptin secretory response to insulin that, in turn, may be linked to an enhanced rate of adipose tissue glucose utilisation. Studies in man indicate that a small birth weight is associated with insulin resistance and increased prevalence of the insulin resistance syndrome in later life. 20 -23 In contrast, in the present study, early growth retardation elicited by a low-protein diet was associated with enhanced whole-body insulin sensitivity. 26 -28 However, it has been reported that low-protein offspring undergo an age-dependent loss of glucose tolerance, eventually developing impaired glucose tolerance compared with control offspring on ageing. 37 The potential link between elevated insulin-stimulated leptin levels in early-protein-restricted rats and the subsequent development of insulin resistance and type 2 diabetes remains to be elucidated. It has recently been demonstrated that the anorexic and anti-lipopenic actions of leptin decline with age, possibly through increased SOCS-3 expression. 38 It is therefore possible that, although early growth retardation is associated with increased insulin-stimulated leptin secretion, early growth retardation leads to a more rapid or greater loss of leptin sensitivity with ageing, leading to abnormalities in lipid metabolism and the accelerated development of insulin resistance.
Support for a potential direct role of adipose tissue in regulating systemic glucose homeostasis has accrued from studies with the b3 adrenergic agonist CL316,243. 39, 40 Increasing glucose uptake selectively in adipose tissue results in enhanced sensitivity of whole-body glucose uptake to insulin in the absence of any change in muscle glucose uptake. The pattern of relative change of R d observed in response to changes in insulin status in the early-proteinrestricted group compared with the control group in the present study bore a striking parallel to the responses of both adipose tissue glucose utilisation and plasma leptin concentrations. It can be concluded that early-protein-restriction influences peripheral insulin-stimulated glucose disposal to an extent that can be positively related to adipose tissue glucose utilisation and excursions in plasma leptin levels. Although the present data do not necessarily imply a causal relationship, it is now established that leptin has a clear insulin-sensitising effect both acutely and after chronic administration to normal rodents. 7, 41, 42 Thus, enhanced adipocyte glucose handling programmed by early protein restriction may feed-forward to enhance peripheral insulin action via the changes in leptin secretion that it induces.
In the present experiments, it was observed that postabsorptive plasma leptin levels were significantly depressed, relative to control, by early protein restriction. In isolated adipocytes, leptin secretion is reciprocally related to the lipolytic rate, as assessed from glycerol release. 43 Extrapolating to the in vivo situation, it would be predicted that rates of lipolysis in the early-protein-restricted group in the postabsorptive state would be relatively high, even though glucose uptake rates are elevated compared with the control. In adipose tissue, fatty acid esterification to triglyceride can be fuelled by glycerol 3-phosphate derived in part from glucose. It is therefore tempting to speculate that leptin secretion by the adipocyte is in some way related to overall adipocyte fuel homeostasis, rather than to glucose utilisation alone, through an as yet undefined lipid metabolite coupling factor. Irrespective of the mechanism of adipocyte glucose and lipid sensing, the present findings clearly predict that excursions in circulating leptin concentrations evoked by feeding (elevated insulin) and fasting (lowered insulin) are exaggerated in the early-protein-restricted group through long-term effects to programme adipocyte glucose handling.
